Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Scleral thinning is a loss of thickness in the sclera that makes the eye wall weaker and more translucent. It can appear as a bluish or darkened area where underlying tissues show through. Thinning can be localized or widespread and can develop slowly over time. The main concern is fragility, since advanced thinning raises the risk of rupture or perforation.
read more about scleral thinning ...Scleral thinning can result from autoimmune inflammation, especially forms of scleritis that damage scleral blood supply and tissue structure. Prior eye surgery and trauma can also lead to localized thinning, particularly when healing is complicated by infection or poor tissue health. Degenerative and congenital connective tissue conditions can contribute, and high myopia can be linked with overall scleral stretching in some cases. Infections that involve the sclera can erode tissue and leave weak areas even after treatment. A full evaluation looks for both local triggers and systemic disease drivers.
Many people have no symptoms and first notice a color change in the white of the eye. Some notice mild irritation or dryness when the surface becomes irregular or inflamed nearby. When inflammation is active, pain and tenderness can occur, especially in scleritis-linked thinning. Vision changes are not typical from thinning alone, but they can occur when corneal or retinal complications coexist. Sudden pain, new bulging, or rapid vision loss needs urgent care because it can signal impending perforation or another emergency.
Diagnosis starts with slit-lamp exam to document the location, depth, and extent of thinning. The clinician checks for active inflammation, since thinning from scleritis needs different management than thinning from older scarring. Imaging such as anterior segment OCT or ultrasound biomicroscopy can help measure tissue thickness and assess deeper involvement. A dilated exam evaluates the back of the eye for related complications in inflammatory or high-risk cases. Systemic evaluation is considered when thinning suggests autoimmune disease or vasculitis.
Treatment depends on cause, severity, and whether inflammation is active. When thinning is linked with autoimmune inflammation, systemic anti-inflammatory therapy is often used to stop further tissue loss. Protective strategies focus on reducing trauma risk, such as protective eyewear and avoiding rubbing, since fragile tissue tears more easily. When thinning becomes structurally unsafe, surgical reinforcement with grafting materials can restore support and reduce perforation risk. Follow-up visits track stability and help time intervention before complications occur.
Blue sclera is often a visible sign of scleral thinning, since underlying uveal tissue and blood vessels can show through. Blue sclera can also be linked with connective tissue disorders, so the cause matters. Not every case of thinning looks blue, especially when localized. An eye exam helps identify the mechanism and any associated risks.
Yes. Progression depends on the underlying cause, and active inflammatory disease raises the risk of worsening. Post-surgical or scar-related thinning can remain stable, but it still needs monitoring. Regular exams help document change and guide protective planning. Any rapid change needs prompt evaluation.
Contact lenses do not cause scleral thinning, but surface friction can aggravate irritation in some eyes with fragile tissue or surface disease. Certain specialty lenses can be used therapeutically in select cases, but lens choice depends on the location and severity of thinning. An eye doctor can advise whether contact lenses are safe for a specific situation. If redness or pain increases after lens wear, stop and get checked.
Scleral thinning: Causes, diagnosis, and management. PubMed. https://pubmed.ncbi.nlm.nih.gov/36716993/. Date Accessed February 4, 2026.
Scleritis. EyeWiki. https://eyewiki.org/Scleritis. Date Accessed February 4, 2026.
Surgically-Induced Necrotizing Scleritis. EyeWiki. https://eyewiki.org/Surgically-Induced_Necrotizing_Scleritis. Date Accessed February 4, 2026.
Scleromalacia Perforans. EyeWiki. https://eyewiki.org/Scleromalacia_Perforans. Date Accessed February 4, 2026.
Senile Scleral Plaque. EyeWiki. https://eyewiki.org/Senile_Scleral_Plaque. Date Accessed February 4, 2026.